Design and development of novel bioadhesive niosomal formulation for the transcorneal delivery of anti-infective agent: In-vitro and ex-vivo investigations
Open accessThe DOI matches its Crossref record.
Abstract
Gatifloxacin eye drops are frequently used in eye infections. However such formulations have a major drawback i.e. short duration of action and usually require 4–6 times installations daily. A chitosan coated niosomal formulation of gatifloxain was purposed to show a longer retention time on eyes and subsequent reduction in dosing frequency. Vesicles were prepared by solvent injection method using cholesterol and Span-60. An extensive optimization of formulation was done using different ratios of cholesterol, Span-60 and drug, revealed NS60-5 (cholesterol: span-60 50: 50 and drug content of 20 mg) to be the optimized niosome formulation. NS60-5 had shown a highest entrapment efficiency of 64.9 ± 0.66% with particle size 213.2 ± 1.5 nm and zeta potential −34.7 ± 2.2 mV. Optimized niosomes were also coated with different concentrations of chitosan and evaluated. Permeation studies had revealed that optimized niosomes (86.77 ± 1.31%) had increased the transcorneal permeation of Gatifloxacin more than two fold than simple drug solution (37.19 ± 1.1%). Longer retention potential of the coated niosomes was further verified by fluorescence microscopy. Study revealed that simple dye solution got easily washed out with in 6 h. The uncoated niosomes (NS60-5) showed a longer retention (more than 6 h), which was further enhanced in case of coated niosomes i.e. CNS60-1 (more than 12 h). Antimicrobial studies had shown the better efficacy of CNS60-1 (zone of inhibition) when compared to marketed formulation. The final chitosan formulation was found to have shown better ocular tolerability as demonstrated by corneal hydration test histopathology investigations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Chen, S., Hanning, S., Falconer, J., Locke, M., & Wen, J. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.08.015 · Cited by 460
Ocular Drug Delivery: a Comprehensive Review
Ahmed, S., Amin, M. M., & Sayed, S. (2023) · AAPS PharmSciTech · doi:10.1208/s12249-023-02516-9 · Cited by 352
Niosomal drug delivery systems for ocular disease-recent advances and future prospects
Durak, S., Esmaeili Rad, M., Alp Yetisgin, A., Eda Sutova, H., Kutlu, O., Cetinel, S., & Zarrabi, A. (2020) · Nanomaterials · doi:10.3390/nano10061191 · Cited by 196
Dermal targeting of Centella asiatica extract using hyaluronic acid surface modified niosomes
Wichayapreechar, P., Anuchapreeda, S., Phongpradist, R., Rungseevijitprapa, W., & Ampasavate, C. (2020) · Journal of Liposome Research · doi:10.1080/08982104.2019.1614952 · Cited by 43
“…of counter ions or the preferential adsorption of hydroxyl ions at the vesicle surface or the presence of impurities consisting in cholesterol and surfactant raw materials rather than the free carboxyl groups in cholesterol and surfactant molecules (Junyaprasert et al. 2008, Zubairu et al. 2015).”
BackgroundA Comprehensive Review on Niosomes as a Tool for Advanced Drug Delivery
Sharma, S., Garg, A., Agrawal, R., Chopra, H., & Pathak, D. (2024) · Pharmaceutical Nanotechnology · doi:10.2174/2211738511666230726154557 · Cited by 25
Metadata
- Authors
- Zubairu, Y., Negi, L. M., Iqbal, Z., & Talegaonkar, S.
- Venue
- Asian Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 10
- Issue
- 4
- Pages
- 322-330
- ISSN
- 1818-0876 (ISSN-L)
- OpenAlex
- W2028839775
- Cited by
- 77
- References
- 0
- FWCI
- 1.51
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Design and development of novel bioadhesive niosomal formulation for the transcorneal delivery of anti-infective agent: In-vitro and ex-vivo investigations. https://app.cochat.ai/papers/10.1016/j.ajps.2015.02.001
- The paper
- Zubairu, Y., Negi, L. M., Iqbal, Z., & Talegaonkar, S. (2015). Design and development of novel bioadhesive niosomal formulation for the transcorneal delivery of anti-infective agent: In-vitro and ex-vivo investigations. Asian Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.ajps.2015.02.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.